# CGM for Healthy People: Useful N=1 Toy, or Marketing in a Sticker?

If you are healthy, no randomized trial shows that wearing a continuous glucose monitor improves heart, metabolic, or longevity outcomes; it is an interesting N=1 experiment, not a proven intervention. Healthy adults average around 99 mg/dL and stay between 70 and 140 mg/dL roughly 96% of the day, so quick post-meal bumps to 140 mg/dL are normal. For a fraction of the EUR 800 to 1,800 a year a self-payer spends on sensors in DACH, validated blood markers like HbA1c, fasting insulin and an OGTT give you decades of evidence.

You can now buy a glucose monitor over the counter as a healthy adult in the US. They are slowly showing up in DACH too. The science says they show you interesting patterns, not proven longevity gains. Here is the honest read.

## On this page

- What does a CGM actually measure?
- What do healthy people's glucose numbers really look like?
- What can you actually learn in two weeks on a CGM?
- Where does the marketing get ahead of the science?
- Can you even buy a CGM in DACH right now?
- What does the research actually validate instead?

## FAQ

- Do I need a CGM if I am healthy?
- How accurate are CGMs really?
- Lingo vs Libre vs Stelo, what is the difference?
- Is a post-meal spike to 145 mg/dL bad?
- Hello Inside vs Levels Health, are they worth it?
- What should my glucose be?
- Insider tip or waste of money?

## Sources

- Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al.. (2019). Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. https://doi.org/10.2337/dci19-0028
- Hall H, Perelman D, Breschi A, Limcaoco P, Kellogg R, McLaughlin T, Snyder M. (2018). Glucotypes reveal new patterns of glucose dysregulation. PLOS Biology. https://doi.org/10.1371/journal.pbio.2005143
- Shah VN, DuBose SN, Li Z, Beck RW, Peters AL, Weinstock RS, et al.. (2019). Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-02763
- American Diabetes Association Professional Practice Committee. (2025). 7. Diabetes Technology: Standards of Care in Diabetes — 2025. Diabetes Care. https://doi.org/10.2337/dc25-S007
- American Diabetes Association Professional Practice Committee. (2026). 7. Diabetes Technology: Standards of Care in Diabetes — 2026. Diabetes Care. https://diabetesjournals.org/care/article/49/Supplement_1/S150/163922
- Oganesova Z, Pemberton J, Brown A. (2024). Innovative solution or cause for concern? The use of continuous glucose monitors in people not living with diabetes: A narrative review. Diabetic Medicine. https://doi.org/10.1111/dme.15369
- Hanson K, Kipnes M, Tran H. (2024). Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968231225676
- Wright LA, Hirsch IB. (2017). Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2017.0029
- Martinez M, Santamarina J, Pavesi A, Musso C, Umpierrez GE. (2021). Glycemic variability and cardiovascular disease in patients with type 2 diabetes. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2020-002032
- Spartano NL, Sultana N, Lin H, McManus DD, Murabito JM, Benjamin EJ, et al.. (2025). Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae626

_Full guide: https://longevity-germany.com/en/guide/cgm-non-diabetic_

---

_Canonical: https://longevity-germany.com/en/guide/cgm-non-diabetic · Part of Longevity Cities · Updated 2026-06-22_